Dr. Van Haeringen Polygen
ActiveDr. Van Haeringen Polygen has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9k and a net result of €-11k. Equity is shrinking by ~2.8% per year across the filed fiscal years. Its solvency ranks better than 21% of 519 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability0=
Solvency23▼-34
Growth32=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity tight (current ratio 1.13 against 1.38 in 2024), and 86.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13.8%
Return on assets
-17.2%
Age of the figures
9 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€11k
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 519 sector peers (2025).
NBB · sector comparisonPosition among 519 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
7 d late
2024
60 d late
2023
6 d early
2022
67 d early
2021
36 d early
2020
61 d early
2019
57 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€9k▼ 55.5%
2024 · €20k
2018: €20k
2019: €20k
2020: €36k
2021: €82k
2022: €20k
2023: €20k
2024: €20k
2018 → 2025
Total assets
€63k▼ 1.1%
2024 · €64k
2018: €116k
2019: €148k
2020: €105k
2021: €135k
2022: €156k
2023: €87k
2024: €64k
2018 → 2025
Net result
€-11k▼ 1,324%
2024 · €-765
2018: €63k
2019: €57k
2020: €15k
2021: €46k
2022: €19k
2023: €15k
2024: €-765
2018 → 2025
Working capital
€7k▼ 58.0%
2024 · €17k
2018: €18k
2019: €19k
2020: €34k
2021: €80k
2022: €15k
2023: €16k
2024: €17k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€82k-€20k▼ 75.0%€20k=€20k▼ 3.7%€9k▼ 55.5%
Operating result€63k-€25k▼ 60.5%€21k▼ 16.7%€-756€-11k▼ 1,330%
Net result€46k-€19k▼ 59.2%€15k▼ 19.7%€-765€-11k▼ 1,324%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €11k in 2025 against €756 in 2024; the loss grows and 2025 is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €63k
Fixed assets
€2k▼ 40.6%
Current assets
€62k▲ 0.8%
Equity and liabilities €63k
Equity
€9k▼ 55.5%
Debt
€54k▲ 23.1%
The debt ratio rises from 69.3% to 86.2%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€-10k▼
2024 · €554
Cash flow
€-10k▼
2024 · €545
Solvency
13.8%▼
2024 · 30.7%
Current ratio
1.13▼
2024 · 1.38
Quick ratio
1.11▼
2024 · 1.36
Debt / equity
6.23▲
2024 · 2.25
ROE
-124.6%▼
2024 · -3.9%
ROA
-17.2%▼
2024 · -1.2%
Interest coverage
-72.00▼
2024 · 4.29
Debt
€54k▲
2024 · €44k
Debt ≤ 1 year
€54k▲
2024 · €44k
Staff costs
€139k▲
2024 · €113k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€64k€63k▼
Fixed assets21/28€3k€2k▼
Tangible fixed assets22/27€3k€2k▼
Plant, machinery and equipment23€3k€2k▼
Current assets29/58€61k€62k▲
Stocks and contracts in progress3€1k€1k=
Stocks30/36€1k€1k=
Amounts receivable within one year40/41€27k€40k▲
Trade receivables40€20k€33k▲
Other amounts receivable41€7k€7k▲
Current investments50/53€2k-
Cash at bank and in hand54/58€31k€20k▼
Deferred charges and accrued income490/1€797€814▲
Equity and liabilities
Total equity and liabilities10/49€64k€63k▼
Equity10/15€20k€9k▼
Contributions10/11€19k€19k=
Outside capital11€19k-
Other1109/19€19k-
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€0▼
Reserves not available under the articles1311€2k€0▼
Distributable reserves133-€2k
Profit (loss) carried forward14€-765€-12k▼
Amounts payable17/49€44k€54k▲
Amounts payable within one year42/48€44k€54k▲
Current portion of amounts payable after more than one year42-€10k
Trade debts44€9k€12k▲
Suppliers440/4€9k€12k▲
Taxes, remuneration and social security45€35k€32k▼
Taxes450/3€20k€15k▼
Remuneration and social security454/9€14k€17k▲
Income statement
Code20242025
Remuneration, social security and pensions62€113k€139k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€1k▼
Other operating charges640/8€118€298▲
Gross operating margin9900€114k€130k▲
Operating profit (loss)9901€-756€-11k▼
Financial income75/76B€120€52▼
Recurring financial income75€120€52▼
Financial charges65/66B€129€134▲
Recurring financial charges65€129€134▲
Profit (loss) for the period before taxes9903€-765€-11k▼
Profit (loss) for the period9904€-765€-11k▼
Profit (loss) for the period to be appropriated9905€-765€-11k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-765€-12k▼
Profit (loss) brought forward from the previous period14P-€-765
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 7 days late
2025
31-12
Financial
Weakest financial yearnet €-11k
Net result drops to €-11k, the lowest in the series.
29-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 60 days late
2024
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
25-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
25-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-05
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
04-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
28-05
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
29-05
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
30-05
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Malle · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kasteellaan 72390 MalleGround area
318 m²
Building footprint
214 m²
Volume, LiDAR
1,209 m³
Parcel 11049A0748/00M000, Flanders · tallest building 11.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. VAN HAERINGEN POLYGEN BVBA
since 20032.123.654.058
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11049A0748/00M000 | Flanders | 318 m² | 1 · 214 m² | 10.9 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
KST R & D
BE 0762.568.864
Liège · Eq €9k
CREATLEEN CONSULTANCY
BE 0674.954.704
Lokeren · Eq €9k
EURAXI
BE 0786.918.339
Liège · Eq €8k
MSI-DFAT EU
BE 0797.437.790
Jodoigne · Eq €9k
HAPPY DIAB
BE 0803.684.788
Binche · Eq €9k
Of 1,174 companies in sector 72109 we hold annual accounts for 712. 168 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded04-11-2002
Fiscal year end31-12
Activities, NACEBEL
72109Other research and development on natural sciences
73100
85141
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 23 filingsAddress and cadastre registers
Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.